<DOC>
	<DOCNO>NCT00048529</DOCNO>
	<brief_summary>This clinical research study T900607-sodium determine effective safe treat gastric cancer adenocarcinoma esophagus . Patients treat weekly basis intravenous injection study drug .</brief_summary>
	<brief_title>Study T900607-Sodium Subjects With Previously Treated Gastric Cancer Adenocarcinoma Esophagus</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Inclusion Criteria Histologically cytologically confirm diagnosis gastric cancer adenocarcinoma esophagus Subjects must receive 12 regimen prior chemotherapy At least 18 year age Bidimensionally measurable disease amenable CT scanning . At least one lesion must least 1 X 1 cm size . Karnofsky performance status least 70 % Estimated life expectancy least 12 week Females childbearing potential must negative pregnancy test agree use effective contraceptive Subject must able comply study procedure followup examination . Signed write informed consent Lab Values ( obtain â‰¤ 7 day prior study enrollment ) : ANC least 1.5x10e9/L , * Platelet count least 100x10e9/L , Creatinine within 2 time upper limit normal * AST ALT within 5 time upper limit normal Bilirubin within 1.5 time upper limit normal Albumin great 2.5 g/dL Exclusion Criteria Severe , concurrent disease , infection comorbidity , judgment investigator , would make subject inappropriate enrollment NYHA Class III/IV cardiac disease , leave ventricular ejection fraction ( LVEF ) &lt; 50 % , acute anginal symptom Patients receive investigational agent within 4 week enrollment Patients pregnant breastfeed History prior malignancy gastric cancer adenocarcinoma esophagus within last 5 year , except adequately treat basal cell squamous cell skin cancer carcinoma situ cervix History central nervous system metastases carcinomatous meningitis Major surgery within 4 week enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>adenocarcinoma esophagus</keyword>
</DOC>